Drug Shortage Report for TWINRIX
| Report ID | 16553 |
| Drug Identification Number | 02230578 |
| Brand name | TWINRIX |
| Common or Proper name | Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 720UNIT 20MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2017-07-18 |
| Estimated end date | 2017-12-07 |
| Actual end date | 2017-12-04 |
| Shortage status | Resolved |
| Updated date | 2017-12-06 |
| Company comments | Supply released July 10, 2017, August 9, 2017, October 3, 2017, and October 20, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.